Literature DB >> 2921276

Proteinase-like peptidase activities and oestrogen receptor levels in breast cancer tissue.

A Vasishta1, P R Baker, P E Preece, R A Wood, A Cuschieri.   

Abstract

The relationship between proteinase-like peptidase activities and oestrogen receptor levels and status in breast cancer tissue homogenates from 61 patients with breast cancer has been evaluated. With Spearman's rank-order correlation analysis, significant positive correlations were observed between receptor levels and the activities of cathepsin-(B + L)-like, cathepsin-H-like, trypsin-like, plasminogen-activator-like and elastase-like peptidases. In addition, the activities of all but the latter enzyme were significantly higher in patients with receptor-rich tumours than in receptor-poor tumours, and this may have implications for future treatment regimens for patients with oestrogen-receptor-rich tumours. The findings reported are consistent with the suggestion that in breast cancer there may be an association between steroid receptors and proteolytic enzymes such that the release of these enzymes may be under hormonal control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921276     DOI: 10.1007/BF00391606

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors.

Authors:  M J Duffy; P O'Grady; J Simon; M Rose; H R Lijnen
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

2.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7).

Authors:  W B Butler; W L Kirkland; T L Jorgensen
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Plasminogen activator activity and composition in human breast cancer.

Authors:  J L Evers; J Patel; J M Madeja; S L Schneider; G H Hobika; S M Camiolo; G Markus
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

5.  Serum and tissue proteinase-like peptidase activities in women undergoing total mastectomy for breast cancer.

Authors:  A Vasishta; P R Baker; P E Preece; R A Wood; A Cuschieri
Journal:  Eur J Cancer Clin Oncol       Date:  1984-02

Review 6.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

7.  Association of plasminogen activator activity and steroid receptors in human breast cancer.

Authors:  T Thorsen
Journal:  Eur J Cancer Clin Oncol       Date:  1982-02

Review 8.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Relationship of presence of progesterone receptors to prognosis in early breast cancer.

Authors:  M F Pichon; C Pallud; M Brunet; E Milgrom
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

10.  Oestrogen-receptor status and sites of metastasis in breast cancer.

Authors:  F C Campbell; R W Blamey; C W Elston; R I Nicholson; K Griffiths; J L Haybittle
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

View more
  2 in total

1.  Breast carcinoma cellularity and its relation to oestrogen receptor content.

Authors:  D M Parham; P R Baker; A J Robertson; A Vasishta; P G Baker; G Smith
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

2.  Elevated expression and altered processing of fibulin-1 protein in human breast cancer.

Authors:  L M Greene; W O Twal; M J Duffy; E W McDermott; A D Hill; N J O'Higgins; A H McCann; P A Dervan; W S Argraves; W M Gallagher
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.